{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:30:43Z","timestamp":1793079043440,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T00:00:00Z","timestamp":1487894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.014","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:17:17Z","timestamp":1487290637000},"page":"1668-1674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings"],"prefix":"10.1016","volume":"35","author":[{"given":"Robert P.","family":"Lavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair I. MacG.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7771-6678","authenticated-orcid":false,"given":"David J.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Tunceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2017.02.014_b0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/vr.g4996","article-title":"Rabies control and elimination: a test case for One Health","volume":"175","author":"Cleaveland","year":"2014","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.014_b0010","first-page":"3","article-title":"Development in immunoprophylaxis against rabies for animals and humans","volume":"2","author":"Nandi","year":"2010","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/j.vaccine.2017.02.014_b0015","unstructured":"World Health Organization. Rabies: rationale for investing in the global elimination of dog-mediated human rabies. Available at: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/185195\/1\/9789241509558_eng.pdf>; 2015 [accessed 4.4.16]."},{"issue":"9951","key":"10.1016\/j.vaccine.2017.02.014_b0020","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.02.014_b0025","series-title":"Historical perspectives of rabies in Europe and Mediterranean Basin","first-page":"25","article-title":"Rabies in the United Kingdom, Ireland and Iceland","author":"Fooks","year":"2004"},{"key":"10.1016\/j.vaccine.2017.02.014_b0030","first-page":"361","article-title":"Global epidemiology of canine rabies: past, present, and future prospects","volume":"6","author":"Taylor","year":"2016","journal-title":"Vet Med Res Rep"},{"key":"10.1016\/j.vaccine.2017.02.014_b0035","unstructured":"Cleaveland S, Kaare M, Tiringa P, Mlengeya T. A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries. In: Proceedings Southern and Eastern African Rabies Group World Health Organization Meeting, Lilongwe, Malawi; 2001. p. 114\u2013126."},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2017.02.014_b0040","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0264-410X(02)00778-8","article-title":"A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries","volume":"21","author":"Cleaveland","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.014_b0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.vaccine.2012.05.023","article-title":"Human and animal rabies prevention and control cost in Bhutan, 2001-2008: the cost-benefit of dog rabies elimination","volume":"31","author":"Tenzin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.014_b0050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/650733","article-title":"The global burden on nontyhphoidal Salmonella gastroenteritis","volume":"50","author":"Majowicz","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.014_b0055","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.014_b0060","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.02.014_b0065","unstructured":"World Health Organization Expert Consultation on rabies. World Health Organ Tech Rep Ser. 2005;931:1\u201388. [back cover]."},{"key":"10.1016\/j.vaccine.2017.02.014_b0070","unstructured":"National Institute of Allergy and Infectious Disease. Rabies deaths and PEP. Available at: <https:\/\/www.niaid.nih.gov\/news\/events\/meetings\/Viral%20Infections\/Documents\/wilde.pdf>; 2005 [accessed 4.5.16]."},{"key":"10.1016\/j.vaccine.2017.02.014_b0075","unstructured":"Centers for Disease Control and Prevention. Human Rabies. Available at: <http:\/\/www.cdc.gov\/rabies\/location\/usa\/surveillance\/human_rabies.html>; 2015 [accessed 4.5.16]."},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.014_b0080","first-page":"213","article-title":"Rabies in Europe in 2005","volume":"10","author":"Bourhy","year":"2005","journal-title":"Eurosurveillance"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.014_b0085","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3201\/eid1904.121482","article-title":"Rabies update for Latin America and the Caribbean","volume":"19","author":"Vigilato","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.014_b0090","first-page":"185","article-title":"Rabies in Asia: the classical zoonosis","volume":"365","author":"Wilde","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.02.014_b0095","unstructured":"Office International des Epizooties, World Organization for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Available at: <http:\/\/www.oie.int\/en\/international-standard-setting\/terrestrial-manual\/access-online\/>; 2015 [accessed 4.15.16]."},{"key":"10.1016\/j.vaccine.2017.02.014_b0100","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"Rupprecht","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.014_b0105","first-page":"e53","article-title":"Transmission dynamics and prospects for the elimination of canine rabies","author":"Hampson","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2017.02.014_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0035-9203(98)90718-0","article-title":"Epidemiology and control of rabies. The growing problem of rabies in Africa","volume":"92","author":"Cleaveland","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.02.014_b0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1071\/WR10027","article-title":"The use of immunocontraception to improve rabies eradication in urban dog populations","volume":"37","author":"Carroll","year":"2010","journal-title":"Wildlife Res"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.014_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/M13-0542","article-title":"Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania","volume":"160","author":"Fitzpatrick","year":"2014","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.vaccine.2017.02.014_b0125","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.vaccine.2012.03.069","article-title":"Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review","author":"Davlin","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.014_b0130","doi-asserted-by":"crossref","first-page":"e2510","DOI":"10.1371\/journal.pntd.0002510","article-title":"The burden of rabies in Tanzania and its impact on local communities","volume":"7","author":"Sambo","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.02.014_b0135","unstructured":"World Health Organization. Rabies Fact Sheet. Available at: <http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en\/>; 2016 [accessed 4.5.16]."},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.014_b0140","doi-asserted-by":"crossref","first-page":"e83654","DOI":"10.1371\/journal.pone.0083654","article-title":"Costs of rabies control: an economic calculation method applied to Flores Island","volume":"8","author":"Wera","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.014_b0145","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/tbed.12168","article-title":"The cost of canine rabies on four continents","volume":"62","author":"Anderson","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.014_b0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.antiviral.2013.03.004","article-title":"Potential economic benefits of eliminating canine rabies","volume":"98","author":"Shwiff","year":"2013","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.014_b0155","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3201\/eid1612.100958","article-title":"Reemergence of rabies in Chhukha district, Bhutan, 2008","volume":"16","author":"Tenzin","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.014_b0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2656.2012.02033.x","article-title":"Evidence-based control of canine rabies: a critical review of population density reduction","volume":"82","author":"Morters","year":"2013","journal-title":"J Anim Ecol"},{"key":"10.1016\/j.vaccine.2017.02.014_b0165","series-title":"Communicable disease profile: Afghanistan and neighboring countries","author":"World Health Organization (WHO)","year":"2002"},{"key":"10.1016\/j.vaccine.2017.02.014_b0170","unstructured":"World Organization for Animal Health. Toward the Elimination of Rabies in Eurasia. Joint OIE\/WHO\/EU Conference 27-30 May, 2007. Available at: <http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Publications_%26_Documentation\/docs\/pdf\/A_Rabies_Final_Resolution.pdf>; 2007 [accessed 1.17.17]."},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.014_b0175","doi-asserted-by":"crossref","first-page":"e0003447","DOI":"10.1371\/journal.pntd.0003447","article-title":"Review on dog rabies vaccination coverage in Africa: a question of dog accessibility or cost recovery?","volume":"9","author":"Jibat","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.014_b0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2012.03.007","article-title":"The role of vaccination in rabies prevention","volume":"2","author":"Briggs","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.014_b0185","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1365-2664.2008.01468.x","article-title":"Exploring reservoir dynamics: a case study of rabies in the Serengeti ecosystem","volume":"45","author":"Lembo","year":"2008","journal-title":"J Appl Ecol"},{"key":"10.1016\/j.vaccine.2017.02.014_b0190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cvsm.2008.02.011","article-title":"Vaccines for emerging and re-emerging viral diseases of companion animals","volume":"38","author":"McVey","year":"2008","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.014_b0195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2013.12.029","article-title":"How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's expanded program on immunization","volume":"32","author":"Mvundura","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.014_b0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"39\u201340","key":"10.1016\/j.vaccine.2017.02.014_b0205","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.vaccine.2007.06.065","article-title":"An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh","volume":"25","author":"Levin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.014_b0210","unstructured":"World Health Organization, Organization International des Epizooties. Rationale for investing in the global elimination of dog-mediated human rabies. Report of the Rabies Global Conference, Geneva, Switzerland. Available at: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/204621\/1\/WHO_HTM_NTD_NZD_2016.02_eng.pdf>; 2015 [accessed 4.13.16]."},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.014_b0215","doi-asserted-by":"crossref","first-page":"e3270","DOI":"10.1371\/journal.pntd.0003270","article-title":"A one health framework for the evaluation of rabies control programmes: a case study from Colombo City, Sri Lanka","volume":"8","author":"H\u00e4sler","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.02.014_b0220","first-page":"0143","article-title":"Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean","volume":"368","author":"Vigilato","year":"2012","journal-title":"Phil Trans R Soc B"},{"key":"10.1016\/j.vaccine.2017.02.014_b0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3201\/eid1904.120380","article-title":"Response to a rabies epidemic, Bali, Indonesia, 2008\u20132011","volume":"19","author":"Putra","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.014_b0230","doi-asserted-by":"crossref","first-page":"pe1891","DOI":"10.1371\/journal.pntd.0001891","article-title":"Implementation of an intersectoral program to eliminate human and canine rabies: the Bohol Rabies Prevention and Elimination Project","volume":"6","author":"Lapiz","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T03:27:23Z","timestamp":1536031643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17301950"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Merck, Sharp & Dohme Corp., A subsidary of Merck & Co. Inc, Kenilworth, NJ USA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}